Skip to main content
SpringerLink
Log in

Determinants of Hospital Drug Expenditures in Western Europe

  • Guest Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Society of Hospital Pharmacists. ASHP guidelines for the scientific and therapeutic evaluation of drugs for hospital formularies. American Journal of Hospital Pharmacy 38: 1043–1045, 1981

    Google Scholar 

  • Collier J, Foster J. Management of a restricted drugs policy in hospital: the first five years’ experience. Lancet 1: 331–333, 1985

    Article  PubMed  CAS  Google Scholar 

  • Cook J. Clinical pharmacy and cost containment in international therapies. European Journal of Hospital Pharmacy 2(3): 80–82, 1992

    Google Scholar 

  • Dedeoglu N. Health and social inequities in Turkey. Social Science in Medicine 31: 387–392, 1990

    Article  CAS  Google Scholar 

  • Deutsche Krankenhausgesellschaft. Auswertung der Kosten- und Leistungsnachweise 1988, Deutsche Krankenhaus-Verlagsgesellschaft mbH, Dusseldorf, 1990

  • Denig P, Haajer-Ruskamp FM, Versluis A, Wesseling H. Prescribing pattern in a Dutch university hospital. Journal of Clinical Pharmacy and Therapeutics 16: 423–433, 1991

    Article  PubMed  CAS  Google Scholar 

  • Dölle W, Schwabe U. Ist Transparenz auf dem Arzneimittelmarkt mōglich? Internist 27: 21–31, 1986

    PubMed  Google Scholar 

  • Durand-Zaleski I, Bonnet F, Rochant H, Bierling P, Lemaire F. Usefulness of consensus conferences: the case of albumin. Lancet 340: 1388–1390, 1992

    Article  PubMed  CAS  Google Scholar 

  • Faulds D, Lewis NJW, Milne RJ. Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia. PharmacoEconomics 1: 231–249, 1992

    Article  PubMed  CAS  Google Scholar 

  • Feely J, Chan R, Cocoman L, Mulpeter K, O’Connor P. Hospital formularies: need for continuous intervention. British Medical Journal 300: 28–30, 1990

    Article  PubMed  CAS  Google Scholar 

  • Fletcher CV, Metzler D, Borchardt-Phelps P, Rodman JH. Patterns of antibiotic use and expenditures during 7 years at a university hospital. Pharmacotherapy 10: 119–204, 1990

    Google Scholar 

  • Harder S, Thürmann P, Huber T, Rietbrock N. Prescription of drugs not listed in a clinic’s pharmacopoeia: supervision by clinical pharmacologists. European Journal of Clinical Pharmacology 40: 561–564, 1991

    PubMed  CAS  Google Scholar 

  • Hartmann F. Arzneimittelkommission - Erfahrungen an einem Universitätsklinikum. Internist 31: 475–480, 1990

    PubMed  CAS  Google Scholar 

  • Hazlet TK, Hu TW. Association between formulary strategies and hospital drug expenditures. American Journal of Hospital Pharmacy 49(9): 2207–2210, 1992

    PubMed  CAS  Google Scholar 

  • Hirschmann SZ, Meyers BR, Bradbury B, Mehl B, Gendelman S, et al. Use of antimicrobial agents in a university teaching hospital. Archives of Internal Medicine 148: 2001–2007, 1988

    Article  Google Scholar 

  • Jones AL, Hill AS, Soukop M, Hutcheon AW, Cassidy J, et al. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 338: 483–487, 1991

    Article  PubMed  CAS  Google Scholar 

  • Jones-Grizzle AJ, Bootman JL. Pharmacoeconomics of genetically engineered drugs. PharmacoEconomics 1: 45–53, 1992

    Article  PubMed  CAS  Google Scholar 

  • Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Annals of Internal Medicine 79: 555–560, 1973

    PubMed  CAS  Google Scholar 

  • Lipsy RJ. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions. PharmacoEconomics 1: 265–281, 1992

    Article  PubMed  CAS  Google Scholar 

  • London MJ, Friedman JN, Verrier ED, Levin J, Merrick SH, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. Journal of Thoracic and Cardiovascular Surgery 97: 785–797, 1989

    PubMed  CAS  Google Scholar 

  • Marty M, Pouillart P, Scholl S, Droz JP, Azab M, et al. Comparison of the 5-hydroxytryptamine (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. New England Journal of Medicine 322: 816–821, 1990

    Article  PubMed  CAS  Google Scholar 

  • Pearce MJ, Begg EJ. A review of limited lists and formularies: are they cost-effective? PharmacoEconomics 1: 191–202, 1992

    Article  PubMed  CAS  Google Scholar 

  • Plosker GL, Milne RJ. Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy. PharmacoEconomics 2: 285–304, 1992

    Article  PubMed  CAS  Google Scholar 

  • Redelmaier DA, Fuchs VR. Hospital expenditures in the United States and Canada. New England Journal of Medicine 328: 772–778, 1993

    Article  Google Scholar 

  • Rucker D. Quality control of hospital formularies. Pharmaceutisch Weekblad - Scientific Edition 10: 145–150, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sheingold S, Churchill D, Muirhead N, Laupacis A, Labelle R, et al. The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Social Science in Medicine 34: 983–991, 1992

    Article  CAS  Google Scholar 

  • Schwabe U, Paffrath D (Eds). Arzneiverordnungs-Report 92. Gustav Fischer Verlag, Stuttgart Jena 8: 444–455, 1992

  • Sigma-Studie. Gesundheitswesen in acht Ländern, Schweizerische Rückversicherungsgesellschaft, Zürich, 1993

  • Soumerai SB, Ross-Degnan D, Gortmaker S, Avorn J. Withdrawing payment for nonscientific drug therapy: intended and unexpected effects of a large-scale natural experiment. Journal of the American Medical Association 263(6): 831–839, 1990

    Article  PubMed  CAS  Google Scholar 

  • Sutters CA. The management of a hospital formulary. Journal of Clinical Pharmacy and Therapeutics 15: 59–76, 1990

    Article  PubMed  CAS  Google Scholar 

  • Thürmann P, Harder S, Kaiser H, Rietbrock N. Drug utilization and expenditures in a university hospital: a problem for the clinical pharmacologist? International Journal of Clinical Pharmacology. Therapy and Toxicology 30: 468–469, 1992

    Google Scholar 

  • Weeks JC, Tierney MR, Weinstein MC. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. New England Journal of Medicine 325: 81–86, 1991

    Article  PubMed  CAS  Google Scholar 

  • Woo KS, White HD. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents. PharmacoEconomics 3: 192–204, 1993

    Article  PubMed  CAS  Google Scholar 

  • Whittington R, Barradell JB, Benfield P. Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life. PharmacoEconomics 3: 45–82, 1993

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, University Clinic, Theodor-Stern-Kai 7, D-6000, Frankfurt am Main, Federal Republic of Germany

    Petra Thürmann & Sebastian Harder

Authors
  1. Petra Thürmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Harder
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thürmann, P., Harder, S. Determinants of Hospital Drug Expenditures in Western Europe. Pharmacoeconomics 4, 157–161 (1993). https://doi.org/10.2165/00019053-199304030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199304030-00001

Search

Navigation